ArriVent BioPharma | 8-K: Current report
ArriVent BioPharma | 8-K: Current report
ArriVent BioPharma | 8-K: ArriVent BioPharma Reports First Quarter 2024 Financial Results
ArriVent BioPharma | 8-K: Current report
ArriVent BioPharma | 8-K: Current report
ArriVent BioPharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ArriVent BioPharma | 8-K: Current report
ArriVent BioPharma, Inc. | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
ArriVent BioPharma, Inc. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
ArriVent BioPharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
ArriVent BioPharma | S-1: General form for registration of securities under the Securities Act of 1933
No Data